Masters Capital Management’s Asensus Surgical, Inc. ASXC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,000,000
| Closed | -$666K | – | 83 |
|
|
2024
Q2 | $666K | Hold |
2,000,000
| – | – | 0.04% | 64 |
|
|
2024
Q1 | $460K | Hold |
2,000,000
| – | – | 0.02% | 67 |
|
|
2023
Q4 | $638K | Hold |
2,000,000
| – | – | 0.03% | 61 |
|
|
2023
Q3 | $540K | Hold |
2,000,000
| – | – | 0.03% | 58 |
|
|
2023
Q2 | $1.01M | Buy |
2,000,000
+157,000
| +9% | +$93.8K | 0.04% | 57 |
|
|
2023
Q1 | $1.21M | Buy |
+1,843,000
| New | +$1.25M | 0.06% | 54 |
|
|
2021
Q1 | – | Sell |
-900,000
| Closed | -$562K | – | 82 |
|
|
2020
Q4 | $562K | Hold |
900,000
| – | – | 0.03% | 59 |
|
|
2020
Q3 | $313K | Hold |
900,000
| – | – | 0.02% | 50 |
|
|
2020
Q2 | $487K | Sell |
900,000
-132,553
| -13% | -$64K | 0.06% | 46 |
|
|
2020
Q1 | $363K | Buy |
1,032,553
+779,129
| +307% | +$813K | 0.04% | 49 |
|
|
2019
Q4 | $373K | Sell |
253,424
-17,537
| -6% | -$60.9K | 0.02% | 50 |
|
|
2019
Q3 | $2.18M | Sell |
270,961
-18,236
| -6% | -$248K | 0.13% | 55 |
|
|
2019
Q2 | $5.11M | Buy |
289,197
+177,724
| +159% | +$3.89M | 0.25% | 52 |
|
|
2019
Q1 | $3.45M | Sell |
111,473
-23,142
| -17% | -$776K | 0.18% | 58 |
|
|
2018
Q4 | $3.96M | Buy |
134,615
+57,692
| +75% | +$2.62M | 0.22% | 51 |
|
|
2018
Q3 | $5.8M | Sell |
76,923
-18,193
| -19% | -$1.23M | 0.14% | 72 |
|
|
2018
Q2 | $5.39M | Sell |
95,116
-212,576
| -69% | -$7.74M | 0.15% | 62 |
|
|
2018
Q1 | $6.8M | Buy |
307,692
+9,615
| +3% | +$220K | 0.15% | 64 |
|
|
2017
Q4 | $7.48M | Sell |
298,077
-9,615
| -3% | -$296K | 0.18% | 57 |
|
|
2017
Q3 | $5.72M | Hold |
307,692
| – | – | 0.13% | 63 |
|
|
2017
Q2 | $2.84M | Buy |
307,692
+161,629
| +111% | +$1.54M | 0.07% | 65 |
|
|
2017
Q1 | $2.3M | Hold |
146,063
| – | – | 0.06% | 64 |
|
|
2016
Q4 | $2.47M | Sell |
146,063
-7,783
| -5% | -$160K | 0.05% | 65 |
|
|
2016
Q3 | $3.38M | Buy |
153,846
+4,288
| +3% | +$78.4K | 0.07% | 61 |
|
|
2016
Q2 | $2.37M | Sell |
149,558
-81,211
| -35% | -$2.55M | 0.07% | 55 |
|
|
2016
Q1 | $12.8M | Sell |
230,769
-121,230
| -34% | -$5.19M | 0.27% | 47 |
|
|
2015
Q4 | $11.3M | Buy |
351,999
+121,230
| +53% | +$3.9M | 0.3% | 45 |
|
|
2015
Q3 | $6.78M | Buy |
230,769
+30,769
| +15% | +$1.14M | 0.23% | 41 |
|
|
2015
Q2 | $7.8M | Buy |
200,000
+123,077
| +160% | +$5.67M | 0.26% | 48 |
|
|
2015
Q1 | $2.93M | Buy |
76,923
+53,595
| +230% | +$2.02M | 0.08% | 61 |
|
|
2014
Q4 | $883K | Buy |
23,328
+442
| +2% | +$18.2K | 0.02% | 57 |
|
|
2014
Q3 | $1.3M | Sell |
22,886
-191
| -0.8% | -$10.3K | 0.05% | 50 |
|
|
2014
Q2 | $1.51M | Buy |
+23,077
| New | +$1.33M | 0.07% | 49 |
|
Other funds holding ASXC
Masters Capital Management's ASXC Position: Q3 2024 in Review
Masters Capital Management sold out of Asensus Surgical, Inc. (ASXC) in Q3 2024, closing a stake of 2,000,000 shares — an estimated $666K sold.
Masters Capital Management first reported a position in ASXC in Q2 2014 and held it in 33 quarters. The position peaked at $12.8M in Q1 2016. 1 fund tracked by Wall St. Rank holds ASXC as of Q3 2024.
- Masters Capital Management reported no remaining Asensus Surgical, Inc. position as of Q3 2024 after selling out during the quarter.
- Masters Capital Management sold 2,000,000 Asensus Surgical, Inc. shares in Q3 2024, an estimated $666K.
- Masters Capital Management first reported a position in Asensus Surgical, Inc. in Q2 2014 and held it in 33 quarters.
- Masters Capital Management's Asensus Surgical, Inc. position peaked at $12.8M in Q1 2016.
- 1 fund tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2024.
Based on Masters Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.